- Previous Close
32.800 - Open
32.900 - Bid 31.100 x --
- Ask 32.500 x --
- Day's Range
29.950 - 33.000 - 52 Week Range
13.500 - 35.000 - Volume
57,000 - Avg. Volume
88,747 - Market Cap (intraday)
11.153B - Beta (5Y Monthly) --
- PE Ratio (TTM)
1,565.00 - EPS (TTM)
0.020 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Jiangxi Rimag Group Co., Ltd. operates medical imaging centers in China. The company offers imaging examination and diagnostic service, such as MRI, CT, PET, X-ray, ultrasound, and mammography to patients and other healthcare consumers; imaging solution services; and Rimag Cloud services, including cloud storage and cloud film module services, cloud radiology information system services, cloud Picture Archive and Communication System services, and imaging AI integration platform modules and operational management modules. It also operates and manages medical imaging platform that provides diversified imaging services; research and development center; and sells medical equipment and consumables. The company was incorporated in 2014 and is headquartered in Beijing, China.
www.rimag.com.cn1,667
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 2522.HK
View More
Performance Overview: 2522.HK
Trailing total returns as of 10/22/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 2522.HK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 2522.HK
View MoreValuation Measures
Market Cap
11.69B
Enterprise Value
11.82B
Trailing P/E
2.03k
Forward P/E
80.65
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
13.14
Price/Book (mrq)
7.01
Enterprise Value/Revenue
13.29
Enterprise Value/EBITDA
683.02
Financial Highlights
Profitability and Income Statement
Profit Margin
0.65%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
812.85M
Net Income Avi to Common (ttm)
5.27M
Diluted EPS (ttm)
0.020
Balance Sheet and Cash Flow
Total Cash (mrq)
322.54M
Total Debt/Equity (mrq)
27.66%
Levered Free Cash Flow (ttm)
--
Research Analysis: 2522.HK
View MoreCompany Insights: 2522.HK
2522.HK does not have Company Insights